Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 197Leukemia 110Lymphoma 90Precursor Cell Lymphoblastic Leukemia-Lymphoma 86Burkitt Lymphoma 52Myelodysplastic Syndromes 47Lymphoma, Mantle-Cell 47Lymphoma, Large B-Cell, Diffuse 47Lymphoma, Non-Hodgkin 46Leukemia, Myelomonocytic, Acute 30Lymphoma, Follicular 29Leukemia, Monocytic, Acute 29Recurrence 25Congenital Abnormalities 25Leukemia, Erythroblastic, Acute 24Lymphoma, Large-Cell, Immunoblastic 23Leukemia, Megakaryoblastic, Acute 23Blast Crisis 21Hodgkin Disease 20Leukemia, Lymphocytic, Chronic, B-Cell 18Leukemia, Myelomonocytic, Chronic 17Leukemia, Myelogenous, Chronic, BCR-ABL Positive 17Lymphoma, B-Cell, Marginal Zone 15Anemia, Refractory, with Excess of Blasts 15Leukemia, Myeloid, Accelerated Phase 13Leukemia, Biphenotypic, Acute 13Leukemia, Myeloid, Chronic-Phase 12Dendritic Cell Sarcoma, Interdigitating 12Myeloproliferative Disorders 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 10

Interventions

venetoclax 1tafasitamab 1fludarabine 1acalabrutinib 1Valganciclovir 1Temozolomide 1Standard of Care 1Radiotherapy 1Lenalidomide 1Drug Therapy 1Cytarabine 1Cyclophosphamide 1Blood Specimen Collection 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pyloric Stenosis, Hypertrophic × Cytarabine × Clear all
NCT07012447 2025-06-10

Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations

The First Affiliated Hospital of Soochow University

Phase 2 Recruiting
32 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Pyloric Stenosis, Hypertrophic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡